Geode Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $298K | Sell |
65,119
-2,445
| -4% | -$11.2K | ﹤0.01% | 3735 |
|
2025
Q1 | $330K | Buy |
67,564
+994
| +1% | +$4.85K | ﹤0.01% | 3688 |
|
2024
Q4 | $447K | Buy |
66,570
+3,879
| +6% | +$26.1K | ﹤0.01% | 3634 |
|
2024
Q3 | $485K | Buy |
62,691
+8,168
| +15% | +$63.2K | ﹤0.01% | 3587 |
|
2024
Q2 | $327K | Sell |
54,523
-82,846
| -60% | -$497K | ﹤0.01% | 3731 |
|
2024
Q1 | $1.24M | Buy |
137,369
+1,904
| +1% | +$17.2K | ﹤0.01% | 3282 |
|
2023
Q4 | $1.28M | Buy |
135,465
+6,203
| +5% | +$58.8K | ﹤0.01% | 3248 |
|
2023
Q3 | $1.54M | Buy |
129,262
+5,586
| +5% | +$66.5K | ﹤0.01% | 3169 |
|
2023
Q2 | $3.03M | Buy |
123,676
+20,180
| +19% | +$494K | ﹤0.01% | 2963 |
|
2023
Q1 | $3.24M | Buy |
103,496
+5,807
| +6% | +$182K | ﹤0.01% | 2821 |
|
2022
Q4 | $6.88M | Buy |
97,689
+3,599
| +4% | +$253K | ﹤0.01% | 2483 |
|
2022
Q3 | $8.1M | Buy |
94,090
+16,479
| +21% | +$1.42M | ﹤0.01% | 2387 |
|
2022
Q2 | $6.42M | Buy |
77,611
+10,188
| +15% | +$842K | ﹤0.01% | 2559 |
|
2022
Q1 | $11.2M | Buy |
67,423
+5,616
| +9% | +$933K | ﹤0.01% | 2278 |
|
2021
Q4 | $10.3M | Buy |
61,807
+1,339
| +2% | +$224K | ﹤0.01% | 2422 |
|
2021
Q3 | $5.22M | Buy |
60,468
+3,122
| +5% | +$270K | ﹤0.01% | 2890 |
|
2021
Q2 | $3.11M | Buy |
57,346
+6,113
| +12% | +$332K | ﹤0.01% | 3130 |
|
2021
Q1 | $3.05M | Buy |
51,233
+4,182
| +9% | +$249K | ﹤0.01% | 3039 |
|
2020
Q4 | $2.46M | Buy |
47,051
+4,145
| +10% | +$216K | ﹤0.01% | 2970 |
|
2020
Q3 | $2.08M | Buy |
42,906
+1,006
| +2% | +$48.7K | ﹤0.01% | 2860 |
|
2020
Q2 | $2.17M | Sell |
41,900
-352
| -0.8% | -$18.2K | ﹤0.01% | 2794 |
|
2020
Q1 | $1.84M | Buy |
42,252
+29,307
| +226% | +$1.28M | ﹤0.01% | 2713 |
|
2019
Q4 | $519K | Buy |
12,945
+386
| +3% | +$15.5K | ﹤0.01% | 3488 |
|
2019
Q3 | $411K | Buy |
12,559
+467
| +4% | +$15.3K | ﹤0.01% | 3538 |
|
2019
Q2 | $932K | Buy |
12,092
+2,714
| +29% | +$209K | ﹤0.01% | 3259 |
|
2019
Q1 | $1.66M | Buy |
9,378
+3,573
| +62% | +$634K | ﹤0.01% | 2959 |
|
2018
Q4 | $1.37M | Buy |
5,805
+3,244
| +127% | +$765K | ﹤0.01% | 2968 |
|
2018
Q3 | $548K | Buy |
+2,561
| New | +$548K | ﹤0.01% | 3428 |
|